Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      TERMINATED
      Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance
      Description

      The purpose of the study is to learn about the effects of the drug, lenalidomide (Revlimid®), on neuropathy (damage to the nerves that affect feelings and strength) associated with Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS).

      Conditions
      NeuropathyNonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)
      Talk to us